Evidence map›Paper›PMID 36585443›Full record

ArticleNature chemistry2023

A synergistic Rh(I)/organoboron-catalysed site-selective carbohydrate functionalization that involves multiple stereocontrol.

V U Bhaskara Rao, Caiming Wang, Daniel P Demarque, Corentin Grassin, Felix Otte, Christian Merten, Carsten Strohmann, Charles C J Loh

Abstract read
In one paragraph

Article in Nature chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

V U Bhaskara Rao *Abteilung Chemische Biologie, Max Planck Institut für Molekulare Physiologie, Dortmund, Germany.ORCID http://orcid.org/0000-0002-3488-687X
Caiming Wang *Abteilung Chemische Biologie, Max Planck Institut für Molekulare Physiologie, Dortmund, Germany.
Daniel P DemarqueRuhr-University Bochum, Organic Chemistry II, Bochum, Germany.
Corentin GrassinRuhr-University Bochum, Organic Chemistry II, Bochum, Germany.ORCID http://orcid.org/0000-0002-7605-0878
Felix OtteDepartment of Inorganic Chemistry, Technische Universität Dortmund, Dortmund, Germany.
Christian MertenRuhr-University Bochum, Organic Chemistry II, Bochum, Germany.ORCID http://orcid.org/0000-0002-4106-1905
Carsten StrohmannDepartment of Inorganic Chemistry, Technische Universität Dortmund, Dortmund, Germany.ORCID http://orcid.org/0000-0002-4787-2135
Charles C J LohAbteilung Chemische Biologie, Max Planck Institut für Molekulare Physiologie, Dortmund, Germany. chuanjie.loh@mpi-dortmund.mpg.de.ORCID http://orcid.org/0000-0001-6970-1989

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) ME 4267/5-1
6 · The paper itself

Abstract

Site-selective functionalization is a core synthetic strategy that has broad implications in organic synthesis. Particularly, exploiting chiral catalysis to control site selectivity in complex carbohydrate functionalizations has emerged as a leading method to unravel unprecedented routes into biologically relevant glycosides. However, robust catalytic systems available to overcome multiple facets of stereoselectivity challenges to this end still remain scarce. Here we report a synergistic chiral Rh(I)- and organoboron-catalysed protocol, which enables access into synthetically challenging but biologically relevant arylnaphthalene glycosides. Our method depicts the employment of chiral Rh(I) catalysis in site-selective carbohydrate functionalization and showcases the utility of boronic acid as a compatible co-catalyst. Crucial to the success of our method is the judicious choice of a suitable organoboron catalyst. We also determine that exquisite multiple aspects of stereocontrol, including enantio-, diastereo-, regio- and anomeric control and dynamic kinetic resolution, are concomitantly operative.

Identifiers

PMID36585443
PMCPMC9986112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.